NBO Pharma Inc.
New Filing
CIK: 0002103906·Pharmaceuticals·DELAWARE·Filed: Jan 22, 2026
Total Offering
$7,640,217
Amount Sold
$7,640,217
Investors
93
First Sale
Jun 12, 2025
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(c)
Related Persons
| Name | Role |
|---|---|
| Fredric David Price | Executive Officer, Director |
| Robert Friedman | Director |
| Colin Foster | Director |
| Bard Geesaman | Director |
Company
SEC Filing
0002103906-26-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free